Newsroom
Sorted by: Latest
-
Kraft Heinz Commences Cash Tender Offer for Up To $1.1 Billion Aggregate Purchase Price of Certain of its Outstanding Notes
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (“Kraft Heinz”) (Nasdaq: KHC) announced today that Kraft Heinz Foods Company, its 100% owned subsidiary (the “Issuer”), has commenced an offer to purchase for cash (the “Tender Offer”) up to the maximum combined aggregate purchase price of $1,100,000,000, excluding accrued and unpaid interest (the “Maximum Tender Amount”), of its outstanding 4.375% Senior Notes due June 2046 and its 4.875% Senior Notes due October 2049 (collectively...
-
Wolters Kluwer brings secure board meeting management to Germany with Legisway Meetings
HÜRTH, Germany--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory today announced the launch of Legisway Meetings in Germany. Legisway Meetings supports company governance boards, supervisory boards, and corporate secretariats in preparing, conducting, and documenting meetings in a secure and structured way, tailored to the increasing governance, accountability, and compliance requirements faced by German organisations. Legisway Meetings is part of the Legisway Suite, Wolters Kluwer’s lega...
-
LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery
GRASSE, France--(BUSINESS WIRE)--LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. “Responsible innovation has always been central to LMR,” said Bertrand de Préville, genera...
-
Wolters Kluwer bringt sichere digitale Sitzungsverwaltung für Vorstände und Aufsichtsräte nach Deutschland mit Legisway Meetings
HÜRTH, Deutschland--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory gibt heute die Einführung von Legisway Meetings in Deutschland bekannt. Legisway Meetings unterstützt Vorstände, Aufsichtsräte und Sekretariate bei der sicheren und strukturierten Vorbereitung, Durchführung und Dokumentation von Sitzungen. Die Lösung ist zugeschnitten auf die wachsenden Anforderungen an Governance, Rechenschaft und Compliance in deutschen Unternehmen. Legisway Meetings ist Teil der Legisway Suite, der Le...
-
Criteo Selects Navan to Modernize Global Travel Management
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. Criteo set out to provide its global workforce with an easy-to-use travel booking experience that brought visibility and control to its travel spending. Prioritizing operational excellence and employee experience, Criteo selected Navan because o...
-
Accenture Partners with the WTA to Help Build the Future of Women’s Tennis
ROME--(BUSINESS WIRE)--Accenture and the Women’s Tennis Association have announced a new, multi-year partnership....
-
ams OSRAM Delivers Strong Q1 Results, Enters AI Market Through a Development Agreement With a Leading AI Photonics Customer and Sees Path to Positive Free Cash Flow in 2027
PREMSTÄTTEN, Austria and MUNICH--(BUSINESS WIRE)--ams OSRAM (SWX:AMS): Key Performance Figures Q1/26: Revenues EUR 796 m, 16.5 % adj. EBITDA margin, in/at the upper half/end of guidance range +9 % year-on-year like-for-like growth in the semiconductor core portfolio at constant FX Free cash flow of EUR 37 m (including disposal proceeds) ‘Simplify’ efficiency & transformation program delivered first savings Digital Photonics Strategy Progress: Augmented Reality smart glasses: full portfolio...
-
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
BERLIN & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced positive topline results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I 124 evuzamitide.1,5 The study met the primary endpoints of sensitivity (the ability of a test to identify individuals who have the condition) and specificity (the ability of a test to identify individuals who do not have the condition) for the diagnosis of...
-
ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social
TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 30 avril 2026 35 511 655 45 235 726 44 998 754 (1) Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement Gé...
-
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Market: Euronext Paris, Compartment C ISIN code: FR0012616852 Date Number of shares outstanding Total voting rights Total gross (1) Total net (2) April 30, 2026 35,511,655 45,235,726 44,998,754 (1) The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basi...